Graf Akcie CAPR (Capricor Therapeutics Inc). Diskuze k akciím CAPR. Aktuální informace CAPR.

Základní informace o společnosti Capricor Therapeutics Inc (Akcie CAPR)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 92.08M
Hodnota podniku (EV) N/A
Tržby 319.591k
EBITDA N/A
Zisk -17.99
Růst v tržbách Q/Q 309.28 %
Růst v tržbách Y/Y -46.71 %
P/E (Cena vůči ziskům) 0.00
Forward P/E -0.22
EV/Sales 232.30
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 288.13
P/FCF N/A
Price/Book 3.27
Účetní hodnota na akcii 1.23
Hotovost na akcii 1.43
FCF vůči ceně -16.79 %
Počet zaměstnanců 26
Tržba na zaměstnance 12.292k
Profit margin -4,401.94 %
Operating margin -5,738.23 %
Gross margin 100.00 %
EBIT margin -5,628.52 %
EBITDA margin -1,593.60 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -8.70 %
EPS - Očekávaný růst příští rok -13.95 %
Return on assets -46.64 %
Return on equity -56.05 %
ROIC -59.73 %
ROCE -48.94 %
Dluhy/Equity 0.23
Čistý dluh/EBITDA 12.43
Current ratio 12.20
Quick Ratio 12.20
Volatilita 7.03
Beta 1.40
RSI 45.46
Cílová cena analytiků 11
Známka akcie (dle analytiků) 1.00
Insider ownership 2.24 %
Institutional ownership 10.25 %
Počet akcií 23.022M
Procento shortovaných akcií 3.32 %
Short ratio 4.08 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2008
Země United States

Finanční výsledky akcie CAPR

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$1.005$1.671$2.666$3.999$5.518$4.787
Cost Of Goods Sold------
Gross Profit$1.005$1.671$2.666$3.999$5.518$4.787
Research And Development Expenses$5.142$12.067$10.766$16.042$13.757$7.787
SG&A Expenses$3.597$4.932$4.763$4.933$4.372$3.017
Other Operating Income Or Expenses------
Operating Expenses$8.739$16.998$15.529$20.975$18.13$10.805
Operating Income$-7.734$-15.327$-12.862$-16.977$-12.612$-6.018
Total Non-Operating Income/Expense$0.092$0.136$15.294$-1.83$-0.246$-0.199
Pre-Tax Income$-7.642$-15.191$2.431$-18.807$-12.857$-6.217
Income Taxes------
Income After Taxes$-7.642$-15.191$2.431$-18.807$-12.857$-6.217
Other Income------
Income From Continuous Operations$-7.642$-15.191$2.431$-18.807$-12.857$-6.217
Income From Discontinued Operations------
Net Income$-7.642$-15.191$2.431$-18.807$-12.857$-6.217
EBITDA$-7.562$-15.169$-12.718$-16.851$-12.501$-5.976
EBIT$-7.734$-15.327$-12.862$-16.977$-12.612$-6.018
Basic Shares Outstanding432221
Shares Outstanding433221
Basic EPS$-2.06$-5.17$1.00$-10.10$-8.10$-5.30
EPS - Earnings Per Share$-2.06$-5.17$0.90$-10.10$-8.10$-5.30
# 2020 2019 2018 2017 2016 2015
Current Ratio11.74266.74899.4053.69922.14281.8426
Long-term Debt / Capital---1.40421.1273.1494
Debt/Equity Ratio----3.4737-8.8739-1.4652
Gross Margin100100100100100100
Operating Margin-769.5197-917.0449-482.399-424.5596-228.5725-125.7231
EBIT Margin-769.5197-917.0449-482.399-424.5596-228.5725-125.7231
EBITDA Margin-752.4102-907.6124-476.9918-421.4156-226.5632-124.8478
Pre-Tax Profit Margin-760.3586-908.908491.1895-470.3319-233.0221-129.8722
Net Profit Margin-760.3586-908.908491.1895-470.3319-233.0221-129.8722
Asset Turnover0.09040.18070.16380.21330.34340.3511
Inventory Turnover Ratio------
Receiveable Turnover11.42498.15827.738117.904126.034313.2878
Days Sales In Receivables31.947744.740247.169520.386414.0227.4688
ROE - Return On Equity-111.7325-329.126421.6572469.79921246.13799.4858
Return On Tangible Equity-111.8387-332.713821.8382453.67741051.48895.8098
ROA - Return On Assets-68.7607-164.280214.9407-100.317-80.0105-45.6027
ROI - Return On Investment-111.7325-329.125921.6572-189.9156-158.262-213.8392
Book Value Per Share1.30851.47044.2736-1.8707-0.6347-5.3376
Operating Cash Flow Per Share2.87530.59892.4793-0.9892-7.6226.6704
Free Cash Flow Per Share-4.02918.32372.5717-0.9985-7.55776.5644